Euronet Worldwide (EEFT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 Apr, 2026Voting matters and shareholder proposals
Dr. Andrzej Olechowski, a director nominee, passed away and is withdrawn from re-election at the 2026 Annual Meeting; no replacement nominee will be named at this time.
Proxies already submitted will be voted only for the remaining nominees; votes for Dr. Olechowski will not be counted.
Stockholders do not need to take action unless they wish to change their vote.
Board of directors and corporate governance
Dr. Olechowski served on the Board for over two decades, contributing significant international finance and economic expertise.
The Board and management expressed condolences and recognized Dr. Olechowski's impact on the company's growth and strategy.
Other Matters
All other information in the Proxy Statement remains unchanged and in effect.
Latest events from Euronet Worldwide
- Q1 2026 saw 40% adjusted EPS growth, strong digital gains, and robust outlook reaffirmed.EEFT
Q1 202630 Apr 2026 - Proxy covers director elections, compensation, auditor ratification, and ESG initiatives.EEFT
Proxy filing13 Apr 2026 - 12% adjusted EPS growth and 6% revenue increase in 2025, led by digital and segment expansion.EEFT
Q4 202512 Feb 2026 - Q2 2024 delivered 11% adjusted EPS growth, strong EFT, and robust digital expansion.EEFT
Q2 20243 Feb 2026 - Q3 2024 saw 9% revenue growth, 45% net income jump, and strong digital expansion.EEFT
Q3 202418 Jan 2026 - Record Q1 growth, 47% net income surge, and 12–16% EPS guidance reaffirmed.EEFT
Q1 202525 Dec 2025 - Record double-digit growth in 2024 and strong 2025 outlook, led by digital and global expansion.EEFT
Q4 202412 Dec 2025 - Q3 2025: 4% revenue growth, 19% adjusted EPS gain, strong digital and strategic expansion.EEFT
Q3 20254 Nov 2025 - Q2 2025 saw double-digit profit growth, digital expansion, and a major U.S. bank deal.EEFT
Q2 202531 Oct 2025